The Journal of Immunology, Vol 156, Issue 8 2801-2808, Copyright © 1996 by American Association of Immunologists

ARTICLES

Induction of anergy in human T helper 0 cells by stimulation with altered T cell antigen receptor ligands

DC Tsitoura, W Holter, A Cerwenka, CM Gelder and JR Lamb
Department of Biology, Imperial College of Science, Technology and Medicine, London, United Kingdom.

CD4+ T cells may become profoundly unresponsive to antigenic restimulation following ligation of TCR by immunogenic peptides bound to MHC class II molecules in the absence of costimulation. Furthermore, it has been reported that anergy can be induced as a consequence of engagement of TCR by analogues of antigenic peptides presented by live APCs. In this study, based on resolution of the crystal structure of an influenza virus hemagglutinin (HA) peptide (HA 306-318) bound to HLA- DRB1*0101, we investigated the potential of analogues with amino acid substitutions at those positions predicted to form interactions with TCR to differentially activate and/or anergize HA-specific human Th0 cells restricted by DR1 class II molecules. For some analogues altering the affinity of peptide/TCR interactions revealed a direct positive correlation between antigenicity and their ability to induce anergy. Nevertheless, certain HA peptide analogues functioned as partial agonists, which although they failed to stimulate clonal expansion, were capable of rendering the Th0 cells unresponsive to immunogenic rechallenge. Furthermore, differences were noticed in the characteristics of the anergic phenotype induced by selected analogues. Restimulation with the native peptide of Th0 cells pre-exposed to the HA analogues in the absence of costimulatory signals failed to uncouple IL-4 and IFN-gamma secretion; however, in some instances, dissociation of proliferation from cytokine production was observed. The ability to differentially signal T cells through changing the affinity of peptide/TCR interactions may have implications in the potential use of altered TCR ligands in immunotherapy.

This article has been cited by other articles:

				M. Kobayashi, N. Abiru, T. Arakawa, K. Fukushima, H. Zhou, E. Kawasaki, H. Yamasaki, E. Liu, D. Miao, F. S. Wong, et al. Altered B:9 23 Insulin, When Administered Intranasally with Cholera Toxin Adjuvant, Suppresses the Expression of Insulin Autoantibodies and Prevents Diabetes J. Immunol., August 15, 2007; 179(4): 2082 - 2088. [Abstract] [Full Text] [PDF]

				A. G. A. Paul, R. van der Zee, L. S. Taams, and W. van Eden A self-hsp60 peptide acts as a partial agonist inducing expression of B7-2 on mycobacterial hsp60-specific T cells: a possible mechanism for inhibitory T cell regulation of adjuvant arthritis? Int. Immunol., July 1, 2000; 12(7): 1041 - 1050. [Abstract] [Full Text] [PDF]

				A. Verhoef and J. R. Lamb Threshold Signaling of Human Th0 Cells in Activation and Anergy: Modulation of Effector Function by Altered TCR Ligand J. Immunol., June 1, 2000; 164(11): 6034 - 6040. [Abstract] [Full Text] [PDF]

				C.-H. Wei, C. Beeson, M. G. Masucci, and V. Levitsky A Partially Agonistic Peptide Acts as a Selective Inducer of Apoptosis in CD8+ CTLs J. Immunol., September 1, 1999; 163(5): 2601 - 2609. [Abstract] [Full Text] [PDF]

				L. C. Korb, S. Mirshahidi, K. Ramyar, A. A. Sadighi Akha, and S. Sadegh-Nasseri Induction of T Cell Anergy by Low Numbers of Agonist Ligands J. Immunol., June 1, 1999; 162(11): 6401 - 6409. [Abstract] [Full Text] [PDF]

				M. Fridkis-Hareli, J. M. Neveu, R. A. Robinson, W. S. Lane, L. Gauthier, K. W. Wucherpfennig, M. Sela, and J. L. Strominger Binding Motifs of Copolymer 1 to Multiple Sclerosis- and Rheumatoid Arthritis-Associated HLA-DR Molecules J. Immunol., April 15, 1999; 162(8): 4697 - 4704. [Abstract] [Full Text] [PDF]

				A. Faith, C. A. Akdis, M. Akdis, A. Joss, D. Wymann, and K. Blaser An Altered Peptide Ligand Specifically Inhibits Th2 Cytokine Synthesis by Abrogating TCR Signaling J. Immunol., February 1, 1999; 162(3): 1836 - 1842. [Abstract] [Full Text] [PDF]

				B. Hemmer, I. Stefanova, M. Vergelli, R. N. Germain, and R. Martin Relationships Among TCR Ligand Potency, Thresholds for Effector Function Elicitation, and the Quality of Early Signaling Events in Human T Cells J. Immunol., June 15, 1998; 160(12): 5807 - 5814. [Abstract] [Full Text] [PDF]

				K. R. Ryan and B. D. Evavold Persistence of Peptide-induced CD4+ T cell Anergy In Vitro J. Exp. Med., January 5, 1998; 187(1): 89 - 96. [Abstract] [Full Text] [PDF]

				J. Madrenas, L. A. Chau, J. Smith, J. A. Bluestone, and R. N. Germain The Efficiency of CD4 Recruitment to Ligand-engaged TCR Controls the Agonist/Partial Agonist Properties of Peptide-MHC Molecule Ligands J. Exp. Med., January 20, 1997; 185(2): 219 - 230. [Abstract] [Full Text] [PDF]